Envisioned by Dr. Ken Dixon, B4CC is a clinical network providing cancer patients with personalized therapies in community based practices. Its goal is to improve cancer survival rates via (1) a private clinical network harvesting tumor tissue and annotated data, (2) analyzing this harvest to connect patients and their treatment teams with precision therapies and research trials, and (3) improving the process of care with a novel business model, appropriate consents, and an underlying proprietary software infrastructure. The company also supplies de-identified tissue and and data to drug development researchers and the bioscience community. B4CC is an important shift in the cancer care landscape that aligns information and access to a patient-empowered treatment experience.